TY - JOUR
T1 - Interaction studies between indomethacin nanocrystals and PEO/PPO copolymer stabilizers
AU - Liu, Peng
AU - Viitala, Tapani
AU - Kartal-Hodzic, Alma
AU - Liang, Huamin
AU - Laaksonen, Timo
AU - Hirvonen, Jouni
AU - Peltonen, Leena
N1 - Funding Information:
The authors acknowledge The Finnish Funding Agency for Innovation (TEKES, Finland; NanoForm project 40187/11) China Scholarship Council and The Academy of Finland for financial support. M.Sc. May Mah from University of Otago and M.Sc. Dongfei Liu from University of Helsinki are acknowledged for valuable discussion and suggestions, and Dr. Petri Ihalainen for providing the AFM image of the indomethacin layer precipitated on the SPR sensor slide.
Publisher Copyright:
© Springer Science+Business Media 2014.
PY - 2015/2
Y1 - 2015/2
N2 - Purpose: The lack of effective screening methods and systemic understanding of interaction mechanisms complicates the stabilizer selection process for nanocrystallization. This study focuses on the efficiency of stabilizers with various molecular compositions and structures to stabilize drug nanocrystals. Methods: Five structurally different polymers were chosen as stabilizers for indomethacin nanocrystals. The affinity of polymers onto drug surfaces was measured using surface plasmon resonance (SPR) and contact angle techniques. Nanosuspensions were prepared using the wet-ball milling technique and their physico-chemical properties were thoroughly characterized. Results: SPR and contact angle measurements correlated very well with each other and showed that the binding efficiency decreased in the order L64 > 17R4 > F68 ≈ T908 ≈ T1107, which is attributed to the reduced PPO/PEO ratio and different polymer structures. The electrostatic interactions between the protonated amine of poloxamines and ionized indomethacin enhanced neither the affinity nor the properties of nanosuspensions, such as particle size and physical stability. Conclusions: A good stabilizer should have high binding efficiency, full coverage, and optimal hydrophobic/hydrophilic balance. A high affinity combined with short PEO chains (L64, 17R4) caused poor physical stability of nanosuspensions, whereas moderate binding efficiencies (F68, T908, T1107) with longer PEO chains produced physically stable nanosuspensions.
AB - Purpose: The lack of effective screening methods and systemic understanding of interaction mechanisms complicates the stabilizer selection process for nanocrystallization. This study focuses on the efficiency of stabilizers with various molecular compositions and structures to stabilize drug nanocrystals. Methods: Five structurally different polymers were chosen as stabilizers for indomethacin nanocrystals. The affinity of polymers onto drug surfaces was measured using surface plasmon resonance (SPR) and contact angle techniques. Nanosuspensions were prepared using the wet-ball milling technique and their physico-chemical properties were thoroughly characterized. Results: SPR and contact angle measurements correlated very well with each other and showed that the binding efficiency decreased in the order L64 > 17R4 > F68 ≈ T908 ≈ T1107, which is attributed to the reduced PPO/PEO ratio and different polymer structures. The electrostatic interactions between the protonated amine of poloxamines and ionized indomethacin enhanced neither the affinity nor the properties of nanosuspensions, such as particle size and physical stability. Conclusions: A good stabilizer should have high binding efficiency, full coverage, and optimal hydrophobic/hydrophilic balance. A high affinity combined with short PEO chains (L64, 17R4) caused poor physical stability of nanosuspensions, whereas moderate binding efficiencies (F68, T908, T1107) with longer PEO chains produced physically stable nanosuspensions.
KW - Interaction studies
KW - Nanocrystals
KW - PEO/PPO copolymer
KW - Surface plasmon resonance (SPR)
KW - Wet-ball milling
UR - http://www.scopus.com/inward/record.url?scp=84921458310&partnerID=8YFLogxK
U2 - 10.1007/s11095-014-1491-3
DO - 10.1007/s11095-014-1491-3
M3 - Article
C2 - 25145336
AN - SCOPUS:84921458310
SN - 0724-8741
VL - 32
SP - 628
EP - 639
JO - Pharmaceutical Research
JF - Pharmaceutical Research
IS - 2
ER -